Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

A New Clinical Scale for the Staging of Dementia

Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056 · see citing works

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Evaluating storage, retention, and retrieval in disordered memory and learning

Buschke, H., & Fuld, P. (1974) · Neurology · doi:10.1212/wnl.24.11.1019 · Cited by 1,614 · see citing works

Translating cell biology into therapeutic advances in Alzheimer's disease

Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,588 · see citing works

The <EMPH TYPE="ITAL">APOE</EMPH>-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics

Tang, M.-X. (1998) · JAMA · doi:10.1001/jama.279.10.751 · Cited by 771 · see citing works

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582 · see citing works

Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice

Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.373 · Cited by 573 · see citing works

Untitled work

Selkoe (1999) · doi:10.1038/19866 · Cited by 468 · see citing works

Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease

Joachim, C. L., Mori, H., & Selkoe, D. J. (1989) · Nature · doi:10.1038/341226a0 · Cited by 462 · see citing works

Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees

Ertekin‐Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C. B., Baker, M., Adamson, J. L., Ronald, J., Blangero, J., Hutton, M. L., & Younkin, S. G. (2000) · Science · doi:10.1126/science.290.5500.2303 · Cited by 370 · see citing works

Diagnosis of Dementia in a Heterogeneous Population

Stern, Y. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290035009 · Cited by 370 · see citing works

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Citron, M., Vigo-Pelfrey, C., Teplow, D. B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L., & Selkoe, D. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11993 · Cited by 366 · see citing works

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440108 · Cited by 340 · see citing works

Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

Chen, M., Inestrosa, N. C., Ross, G. S., & Fernandez, H. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2103 · Cited by 320 · see citing works

Standardization of measurement of β-amyloid_(1-42)in cerebrospinal fluid and plasma

Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301 · see citing works

Protease Nexin-II(amyloid β-protein Precursor): a Platelet α-Granule Protein

Nostrand, W. E. V., Schmaier, A. H., Farrow, J. S., & Cunningham, D. D. (1990) · Science · doi:10.1126/science.2110384 · Cited by 296 · see citing works

The role of Aβ42 in Alzheimer's disease

Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282 · see citing works

Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's disease

Demattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M., & Holtzman, D. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00889.x · Cited by 253 · see citing works

Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks

Maestre, G. E., Ottman, R., Stern, Y., Gurland, B. J., Chun, M. R., Tang, M., Shelanski, M. L., Tycko, B., & Mayeux, R. P. (1995) · Annals of Neurology · doi:10.1002/ana.410370217 · Cited by 244 · see citing works

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

Moroney, J. T. (1999) · JAMA · doi:10.1001/jama.282.3.254 · Cited by 222 · see citing works

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly

Romas, S. N., Tang, M.-X., Berglund, L., & Mayeux, R. P. (1999) · Neurology · doi:10.1212/wnl.53.3.517 · Cited by 168 · see citing works

Cholesterol and Alzheimer’s disease

Simons, M., Keller, P., Dichgans, J., & Schulz, J. (2001) · Neurology · doi:10.1212/wnl.57.6.1089 · Cited by 166 · see citing works

Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets.

Li, Q., Whyte, S., Tanner, J. E., Evin, G. M., Beyreuther, K. T., & Masters, C. L. (1998) · PubMed · Cited by 155 · see citing works

Amyloid β protein in plasma from patients with sporadic Alzheimer's disease

Tamaoka, A., Fukushima, T., Sawamura, N., Ishikawa, K., Oguni, E., Komatsuzaki, Y., & Shoji, S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00143-8 · Cited by 154 · see citing works

Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome

Schupf, N., Patel, B. N., Silverman, W. P., Zigman, W. B., Zhong, N., Tycko, B., Mehta, P. D., & Mayeux, R. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01657-3 · Cited by 148 · see citing works

Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy.

Urmoneit, B., Prikulis, I., Wihl, G. E., D’Urso, D., Frank, R. W., Heeren, J., Beisiegel†, U., & Prior, R. (1997) · PubMed · Cited by 124 · see citing works

Amyloid Precursor Protein and Amyloid β Peptide in Human Platelets

Skovronsky, D., Lee, V. M. ‐., & Praticò, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006285200 · Cited by 110 · see citing works

Increased plasma amyloid β protein 1–42 levels in Down syndrome

Mehta, P. D., Dalton, A. J., Mehta, S. P., Kim, K. S., Sersen, E. A., & Wisniewski, H. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00966-x · Cited by 108 · see citing works

A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimerʼs disease and leads to death as early as the age of 28 years

Wısnıewskı, T., Dowjat, W. K., Buxbaum, J. D., et al. (1998) · Neuroreport · doi:10.1097/00001756-199801260-00008 · Cited by 107 · see citing works

Alzheimer's soluble amyloid β is a normal component of human urine

Ghiso, J. A., Calero, M., Matsubara, E., Governale, S., Chuba, J. V., Beavis, R. C., Wısnıewskı, T., & Frangione, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00400-6 · Cited by 90 · see citing works

Stimulated platelets release amyloid β-protein precursor

Cole, G. M., Galasko, D. R., Shapiro, I. P., & Saitoh, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91272-t · Cited by 76 · see citing works

Diagnosis of Dementia in a Heterogeneous Population

Pittman, J. G. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290043010 · Cited by 71 · see citing works

Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets

Smith, C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00738-6 · Cited by 55 · see citing works

Heritability of plasma amyloid β in typical late‐onset Alzheimer’s disease pedigrees

Ertekin‐Taner, N., Graff‐Radford, N. R., Younkin, L. H., Eckman, C. B., Adamson, J. L., Schaid, D. J., Blangero, J., Hutton, M. L., & Younkin, S. G. (2001) · Genetic Epidemiology · doi:10.1002/gepi.1015 · Cited by 53 · see citing works

Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disorders

Vanmechelen, E., Vanderstichele, H., Hulstaert, F., Andreasen, N., Minthon, L., Winblad, B. G., Davidsson, P., & Blennow, K. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00304-9 · Cited by 48 · see citing works

Novel Presenilin 1 Mutations Associated With Early Onset of Dementia in a Family With Both Early-Onset and Late-Onset Alzheimer Disease

Devi, G., Fotiou, A., Jyrinji, D., Tycko, B., DeArmand, S., Rogaeva, E. A., Song, Y.-Q., Medieros, H., Liang, Y., Orlacchio, A., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1454 · Cited by 41 · see citing works

Amyloid β Protein in Plasma as a Diagnostic Marker for Alzheimer’s Disease

Iwatsubo, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00015-3 · Cited by 37 · see citing works

Quantification of sub-femtomole amounts of Alzheimer amyloid β peptides

Potempska, A., Mack, K., Mehta, P. D., Kim, K. S., & Miller, D. L. (1999) · Amyloid · doi:10.3109/13506129908993283 · Cited by 35 · see citing works

Plasma levels of amyloid ? 40 and 42 are independent from ApoE genotype and mental retardation in down syndrome

Cavani, S., Tamaoka, A., Moretti, A., Marinelli, L., Angelini, G., Stefano, S. D., Piombo, G., Cazzulo, V., Matsuno, S., Shoji, S., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001127)95:3 · Cited by 33 · see citing works

Platelet secretion of β-amyloid is increased in hypercholesterolaemia

Smith, C., Hyatt, P. J., Stanyer, L., & Betteridge, D. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02080-7 · Cited by 20 · see citing works

Untitled work

Kordower (1999) · doi:10.1002/1531-8249(199909)46:3

Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development

Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Epidemiology of Alzheimer disease

Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Plasma β-amyloid in Alzheimer's disease and vascular disease

Janelidze, S., Stomrud, E., Palmqvist, S., Zetterberg, H., van Westen, D., Jeromin, A., Song, L., Hanlon, D., Tan Hehir, C. A., Baker, D., et al. (2016) · Scientific Reports · doi:10.1038/srep26801 · Cited by 626 · see citing works

Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis

Ovod, V., Ramsey, K. N., Mawuenyega, K. G., Bollinger, J. G., Hicks, T., Schneider, T., Sullivan, M., Paumier, K., Holtzman, D. M., Morris, J. C., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.06.2266 · Cited by 585 · see citing works

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573 · see citing works

Chronic stress and glucocorticoids: From neuronal plasticity to neurodegeneration

Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Almeida, O. F. X., Sousa, N., & Sotiropoulos, I. (2016) · Neural Plasticity · doi:10.1155/2016/6391686 · Cited by 297 · see citing works

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial

Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285 · see citing works

Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests

Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247 · see citing works

Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease

Schupf, N., Tang, M. X., Fukuyama, H., Manly, J., Andrews, H., Mehta, P., Ravetch, J., & Mayeux, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805902105 · Cited by 225 · see citing works

Biomarkers for the Early Detection and Progression of Alzheimer's Disease

Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224 · see citing works

Fluid Biomarkers in Alzheimer Disease

Blennow, K., Zetterberg, H., & Fagan, A. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006221 · Cited by 208 · see citing works

Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?

Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174 · see citing works

Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease

Sadowski, M. J., Pankiewicz, J., Scholtzova, H., Mehta, P. D., Prelli, F., Quartermain, D., & Wisniewski, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604011103 · Cited by 167 · see citing works

Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention

Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149 · see citing works

Therapeutic Potential of γ -Secretase Inhibitors and Modulators

Imbimbo, B. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783334015 · Cited by 143 · see citing works

Circulating Biomarkers of Cognitive Decline and Dementia

Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120 · see citing works

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice

Westmark, C. J., Westmark, P. R., O'Riordan, K. J., Ray, B. C., Hervey, C. M., Salamat, M. S., Abozeid, S. H., Stein, K. M., Stodola, L. A., Tranfaglia, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026549 · Cited by 110 · see citing works

Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease

Bishop, G. M., & Robinson, S. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94 · see citing works

Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial

Ma, F., Li, Q., Zhou, X., Zhao, J., Song, A., Li, W., Liu, H., Xu, W., & Huang, G. (2019) · European Journal of Nutrition · doi:10.1007/s00394-017-1598-5 · Cited by 90 · see citing works

Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation

Kauwe, J. S. K., Jacquart, S., Chakraverty, S., Wang, J., Mayo, K., Fagan, A. M., Holtzman, D. M., Morris, J. C., & Goate, A. M. (2007) · Annals of Neurology · doi:10.1002/ana.21099 · Cited by 84 · see citing works

Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer’s disease

Wu, G., Sankaranarayanan, S., Wong, J., Tugusheva, K., Michener, M. S., Shi, X., Cook, J. J., Simon, A. J., & Savage, M. J. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23122 · Cited by 68 · see citing works

Decreased plasma β‐amyloid in the Alzheimer's disease <scp> <i>APP</i> </scp> <scp>A</scp> 673 <scp>T</scp> variant carriers

Martiskainen, H., Herukka, S., Stančáková, A., Paananen, J., Soininen, H., Kuusisto, J., Laakso, M., & Hiltunen, M. (2017) · Annals of Neurology · doi:10.1002/ana.24969 · Cited by 64 · see citing works

Alzheimer's disease biomarkers: correspondence between human studies and animal models

Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.010 · Cited by 27 · see citing works

Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer’s disease

Hsu, J.-L., Lee, W.-J., Liao, Y.-C., Lirng, J.-F., Wang, S.-J., & Fuh, J.-L. (2017) · Scientific Reports · doi:10.1038/s41598-017-05390-1 · Cited by 18 · see citing works

Proposal for Setting Guidance Levels on Entrance Surface Doses for Radiographic Examinations on Children in Japan

Mori, T., Mutoh, H., Satoh, H., et al. (2002) · JAPANES JOURNAL OF MEDICAL INSTRUMENTATION · doi:10.4286/ikakikaigaku.72.2_65

[The incidence of reversible dementia in 145 patients referred on suspicion of dementia].

Pw, N., Jw, K., Feilberg, J. B., et al. (2002) · PubMed · Cited by 1 · see citing works

When memory fails: helping the Alzheimer's and dementia patient

(1994) · Choice Reviews Online · doi:10.5860/choice.32-1564 · Cited by 6 · see citing works

Outcomes After Acute Ischemic Stroke in the United States: Does Residential ZIP Code Matter?

Agarwal, S., Menon, V., & Jaber, W. A. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001629 · Cited by 54 · see citing works

Dementia Risk Prediction: Are We There Yet?

Kamat, S. M., Kamat, A. S., & Grossberg, G. T. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.001 · Cited by 18 · see citing works